Namyang Dairy Products Signs Supply Contract for Special Formula 'XOAllegi' for Galactosemia Patients

[Asia Economy Reporter Seungjin Lee] Namyang Dairy Products announced on the 3rd that it has signed a business agreement with the Population, Health and Welfare Association to supply the special formula milk ‘XO Allegy’ for children with galactosemia.

Galactosemia is a hereditary carbohydrate metabolism disorder caused by the impaired ability to convert galactose, a sugar found in breast milk and regular milk, into glucose. Children born with this congenital disease may experience delayed physical and mental development and have a high risk of developing cataracts, making early diagnosis and treatment essential.

The special formula milk ‘XO Allegy’ produced by Namyang Dairy Products is a product that can help children with galactosemia. Since January, it has been supplied to the Population, Health and Welfare Association, which runs support programs for children with congenital metabolic disorders and their families.

XO Allegy is one of Namyang Dairy Products’ special formula milks produced since 1985 for babies sensitive to lactose and milk proteins. Considering its social contribution, Namyang Dairy Products supplies XO Allegy to the Population, Health and Welfare Association at a price lower than the factory release price. Families of children with galactosemia can apply at their local health center, and upon receiving the application, Namyang Dairy Products will directly send the special formula milk to the family.

Lee Kwang-beom, CEO of Namyang Dairy Products, said, “As a formula milk manufacturer, Namyang Dairy Products has been committed to producing special formula milk for a small number of patients with a sense of mission,” adding, “We will continue to carry out various social contribution activities for patients and marginalized groups.”

Meanwhile, in addition to the XO Allegy product, Namyang Dairy Products continues to produce various special formula milks for a small number of patients. The liquid ketogenic diet product ‘Ketonia,’ developed as the world’s first in 2002, has been produced for 19 years for children with epilepsy and has been supplied free of charge since 2010 through an agreement with Severance Children’s Hospital. Also, the special formula milk for premature infants ‘XO Ireundungi,’ launched in 1985, has been supplied to hospitals and postpartum care centers, its main users, at the same price for 14 years, demonstrating efforts to support a small number of patients.

This content was produced with the assistance of AI translation services.